The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

Elevated opioid neurotransmission in the brain may underlie appetite loss and emotional symptoms in anorexia nervosa.

The FDA granted approval for Journavx after clinical trials demonstrated its effectiveness in post-surgical pain relief ...